Sheila Fallon Friedlander
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sheila Fallon Friedlander has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Bari B. Cunningham
Division of Pediatric and Adolescent Dermatology, Children's Hospital, San Diego and University of California, San Diego Medical School, San Diego, California
2 shared publicationsLawrence F. Eichenfield
2 shared publicationsA.L. Zaenglein
1 shared publication- Aditya Kumar Gupta
Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto , Toronto, Ontario
1 shared publication Albert C. Yan
1 shared publicationAlessandra B. Alió
Division of Pediatric and Adolescent Dermatology, Children's Hospital, San Diego and University of California, San Diego Medical School, San Diego, California
1 shared publication
Latest Publications
- 1 August 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (8) , B6
LB784 Acne fulminans and its variants: Evidence-based expert panel recommendations
- 1 August 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (8) , B6
LB784 Acne fulminans and its variants: Evidence-based expert panel recommendations
- 1 September 2011
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 30 (3) , S6-S11
The Acne Continuum: An Age-Based Approach to Therapy
Acne vulgaris is classically considered a disease of adolescence. Although it most commonly occurs and has been best studied in that age group, it can develop at any time during childhood. It is important that health care practitioners recognize the manifestations of neonatal, infantile and childhood acne, as well as the differential diagnosis and best therapeutic approach in the younger child. Acneiform eruptions in infants and toddlers can occasionally be associated with scarring or with other significant disorders that may be life-threatening. In this article, the authors draw on their own clinical experience as well as the available literature to suggest an age-based approach to managing acne in children from the neonatal period through age 11 years.
- 1 September 2011
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 30 (3) , S6-S11
The Acne Continuum: An Age-Based Approach to Therapy
Acne vulgaris is classically considered a disease of adolescence. Although it most commonly occurs and has been best studied in that age group, it can develop at any time during childhood. It is important that health care practitioners recognize the manifestations of neonatal, infantile and childhood acne, as well as the differential diagnosis and best therapeutic approach in the younger child. Acneiform eruptions in infants and toddlers can occasionally be associated with scarring or with other significant disorders that may be life-threatening. In this article, the authors draw on their own clinical experience as well as the available literature to suggest an age-based approach to managing acne in children from the neonatal period through age 11 years.
- 1 March 2007
- Published by Wiley in Pediatric Dermatology
- Vol. 24 (2) , 130-134
Epstein–Barr Virus‐Associated Genital Ulcers: An Under‐recognized Disorder
Abstract: Infectious mononucleosis is the best‐known syndrome associated with primary Epstein–Barr virus infection. Although a variety of cutaneous and mucosal manifestations are recognized in infectious mononucleosis, genital ulcers have only rarely been described. We describe an otherwise healthy 14‐year‐old girl in whom painful genital ulcers developed during an episode of serologically‐confirmed primary Epstein–Barr virus infection. Clinical, serologic, and histopathologic evaluation failed to disclose evidence of any other etiologic explanation for her lesions. The patient remains well, without recurrence. To date, only 13 instances of genital ulceration in females attributable to Epstein–Barr virus infection have been reported.
- 1 March 2007
- Published by Wiley in Pediatric Dermatology
- Vol. 24 (2) , 130-134
Epstein–Barr Virus‐Associated Genital Ulcers: An Under‐recognized Disorder
Abstract: Infectious mononucleosis is the best‐known syndrome associated with primary Epstein–Barr virus infection. Although a variety of cutaneous and mucosal manifestations are recognized in infectious mononucleosis, genital ulcers have only rarely been described. We describe an otherwise healthy 14‐year‐old girl in whom painful genital ulcers developed during an episode of serologically‐confirmed primary Epstein–Barr virus infection. Clinical, serologic, and histopathologic evaluation failed to disclose evidence of any other etiologic explanation for her lesions. The patient remains well, without recurrence. To date, only 13 instances of genital ulceration in females attributable to Epstein–Barr virus infection have been reported.
- 1 January 2006
- Published by Wiley in Pediatric Dermatology
- Vol. 23 (1) , 21-23
Pityriasis Lichenoides and Idiopathic Thrombocytopenic Purpura in a Young Girl
Pityriasis lichenoides is an inflammatory skin disorder characterized by erythematous, desquamative papules and plaques. An acute form, pityriasis lichenoides et varioliformis acuta, and a chronic form, pityriasis lichenoides chronica, represent the two ends of the spectrum of this disorder. Most commonly seen in children and young adults, its etiology is unknown. We describe a young patient with concurrent pityriasis lichenoides and idiopathic thrombocytopenia purpura, a previously unreported association.
- 1 January 2006
- Published by Wiley in Pediatric Dermatology
- Vol. 23 (1) , 21-23
Pityriasis Lichenoides and Idiopathic Thrombocytopenic Purpura in a Young Girl
Pityriasis lichenoides is an inflammatory skin disorder characterized by erythematous, desquamative papules and plaques. An acute form, pityriasis lichenoides et varioliformis acuta, and a chronic form, pityriasis lichenoides chronica, represent the two ends of the spectrum of this disorder. Most commonly seen in children and young adults, its etiology is unknown. We describe a young patient with concurrent pityriasis lichenoides and idiopathic thrombocytopenia purpura, a previously unreported association.
- 1 December 2005
- Published by SAGE Publications in Lymphatic Research and Biology
- Vol. 3 (4) , 219-225
Recent Progress in Our Understanding of the Pathogenesis of Infantile Hemangiomas
- 1 December 2005
- Published by SAGE Publications in Lymphatic Research and Biology
- Vol. 3 (4) , 219-225
Recent Progress in Our Understanding of the Pathogenesis of Infantile Hemangiomas
- 1 April 2002
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 109 (4) , 602-607
Terbinafine in the Treatment of Trichophyton Tinea Capitis: A Randomized, Double-Blind, Parallel-Group, Duration-Finding Study
Objectives. Terbinafine has been shown to be effective in tinea capitis, using different treatment durations. However, no direct comparison of treatment duration has previously been investigated. This randomized, double-blind, parallel-group, multicenter study was designed to assess the effect of terbinafine treatment duration on the outcome of Trichophyton tinea capitis in a North American population. Methods. A total of 176 patients with a clinical diagnosis of tinea capitis were enrolled in this study and treated with oral terbinafine (3–6 mg/kg/d) for 1, 2, or 4 weeks. All patients were to be followed until week 12. A total of 159 patients had culture-confirmed tinea capitis attributable to Trichophyton species and constituted the intent-to-treat population used for efficacy analysis (50, 55, and 54 patients in the 1-, 2-, and 4-week arms, respectively). Results. At the end of study, effective treatment, defined as negative culture and low scores on signs and symptoms, was achieved in 56%, 69%, and 65% of patients who were treated with terbinafine for 1, 2, and 4 weeks, respectively. A negative culture was achieved in 60%, 76%, and 72%, respectively. Overall, the efficacy data showed that both the 2- and 4-week treatment regimens are clinically superior to the 1-week regimen. Terbinafine was well tolerated, and the incidence of adverse events showed no relationship to the duration of therapy. Conclusion. When efficacy, cost, and compliance are taken into consideration, 2 weeks of terbinafine therapy appears to be the optimal treatment duration for patients with Trichophyton tonsurans tinea capitis.
- 1 April 2002
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 109 (4) , 602-607
Terbinafine in the Treatment of Trichophyton Tinea Capitis: A Randomized, Double-Blind, Parallel-Group, Duration-Finding Study
Objectives. Terbinafine has been shown to be effective in tinea capitis, using different treatment durations. However, no direct comparison of treatment duration has previously been investigated. This randomized, double-blind, parallel-group, multicenter study was designed to assess the effect of terbinafine treatment duration on the outcome of Trichophyton tinea capitis in a North American population. Methods. A total of 176 patients with a clinical diagnosis of tinea capitis were enrolled in this study and treated with oral terbinafine (3–6 mg/kg/d) for 1, 2, or 4 weeks. All patients were to be followed until week 12. A total of 159 patients had culture-confirmed tinea capitis attributable to Trichophyton species and constituted the intent-to-treat population used for efficacy analysis (50, 55, and 54 patients in the 1-, 2-, and 4-week arms, respectively). Results. At the end of study, effective treatment, defined as negative culture and low scores on signs and symptoms, was achieved in 56%, 69%, and 65% of patients who were treated with terbinafine for 1, 2, and 4 weeks, respectively. A negative culture was achieved in 60%, 76%, and 72%, respectively. Overall, the efficacy data showed that both the 2- and 4-week treatment regimens are clinically superior to the 1-week regimen. Terbinafine was well tolerated, and the incidence of adverse events showed no relationship to the duration of therapy. Conclusion. When efficacy, cost, and compliance are taken into consideration, 2 weeks of terbinafine therapy appears to be the optimal treatment duration for patients with Trichophyton tonsurans tinea capitis.
- 1 August 1999
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 104 (2) , 276-279
Use of the Cotton Swab Method in Diagnosing Tinea Capitis
Objective. To evaluate the accuracy of the cotton swab technique for identifying fungal infections of the scalp. The purpose of the study was: 1) to compare the cotton swab technique with the toothbrush method, a popular and reliable means for obtaining specimens; and 2) to ascertain if transport of a specimen, entailing variable transport duration and conditions, impairs the sensitivity and specificity of the technique. Materials and Methods. Part 1 consisted of a prospective, investigator-blinded comparison analysis. Fifty children with scalp findings suspicious for tinea capitis were cultured using both techniques: the toothbrush and cotton swab. Ninety-six culture results were obtained for analysis. The second part of the study consisted of a prospective comparison analysis of cotton swab culture results obtained from samples plated immediately after collection in the physician9s office as compared with samples transported to outside laboratories for processing. Thirty-one children with presumed tinea capitis were cultured twice with the cotton swab technique; one sample was immediately plated onto fungal medium and the other sent to an outside lab, the selection of which was dictated by the patient9s insurance plan. A total of 62 samples were obtained; 58 sample results were used for analysis. Results. In part 1 of the study, 60% of the 48 children analyzed had positive fungal cultures. Eighty percent of these wereTrichophyton species. There was 100% agreement in the results obtained; all patients with positive results using the toothbrush method were also positive when the cotton swab method was used. Similarly, there was complete concordance in laboratory results from the second part of the study. Fifty percent of the 28 children analyzed had positive cultures; 86% grew Trichophytonspecies. All patients who had positive cultures from those samples plated in-office also had positive results from the outside laboratory samples. Conclusions. The cotton swab technique is an easy, atraumatic, inexpensive, and reliable means to evaluate patients with suspected tinea capitis. The method remains sensitive and specific even when transport of these specimens is required and processing is thus delayed. This painless technique requires little technical expertise and can be rapidly performed with a standard cotton tip applicator. It should prove an invaluable aid to practitioners in evaluating patients with possible fungal infections of the scalp.
- 1 August 1999
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 104 (2) , 276-279
Use of the Cotton Swab Method in Diagnosing Tinea Capitis
Objective. To evaluate the accuracy of the cotton swab technique for identifying fungal infections of the scalp. The purpose of the study was: 1) to compare the cotton swab technique with the toothbrush method, a popular and reliable means for obtaining specimens; and 2) to ascertain if transport of a specimen, entailing variable transport duration and conditions, impairs the sensitivity and specificity of the technique. Materials and Methods. Part 1 consisted of a prospective, investigator-blinded comparison analysis. Fifty children with scalp findings suspicious for tinea capitis were cultured using both techniques: the toothbrush and cotton swab. Ninety-six culture results were obtained for analysis. The second part of the study consisted of a prospective comparison analysis of cotton swab culture results obtained from samples plated immediately after collection in the physician9s office as compared with samples transported to outside laboratories for processing. Thirty-one children with presumed tinea capitis were cultured twice with the cotton swab technique; one sample was immediately plated onto fungal medium and the other sent to an outside lab, the selection of which was dictated by the patient9s insurance plan. A total of 62 samples were obtained; 58 sample results were used for analysis. Results. In part 1 of the study, 60% of the 48 children analyzed had positive fungal cultures. Eighty percent of these wereTrichophyton species. There was 100% agreement in the results obtained; all patients with positive results using the toothbrush method were also positive when the cotton swab method was used. Similarly, there was complete concordance in laboratory results from the second part of the study. Fifty percent of the 28 children analyzed had positive cultures; 86% grew Trichophytonspecies. All patients who had positive cultures from those samples plated in-office also had positive results from the outside laboratory samples. Conclusions. The cotton swab technique is an easy, atraumatic, inexpensive, and reliable means to evaluate patients with suspected tinea capitis. The method remains sensitive and specific even when transport of these specimens is required and processing is thus delayed. This painless technique requires little technical expertise and can be rapidly performed with a standard cotton tip applicator. It should prove an invaluable aid to practitioners in evaluating patients with possible fungal infections of the scalp.